Everbright Pharmaceutical Corp. Limited Company Information

Current Status : Live


Everbright Pharmaceutical Corp. Limited's Hong Kong CR Number is 1173046. Incorporation Date is 05-OCT-2007. It's Winding up Mode is . Dissolution date is . Everbright Pharmaceutical Corp. Limited company is of Private company limited by shares Type.
Additional Remarks on the Everbright Pharmaceutical Corp. Limited company are .

Company Data

CRN1173046
Company NameEVERBRIGHT PHARMACEUTICAL CORP. LIMITED
Chinese Name泰達藥業有限公司
Active StatusLive
Register of ChargesUnavailable
TypePrivate company limited by shares
See other companies with same Type - Private company limited by shares
Winding Up Mode
Date of Incorporation05-OCT-2007
See companies with same Incorporation Date - 05-OCT-2007
Date of Dissolution
Remarks
Important Note
Tagspharmaceutical   corp   everbright   
Find Similar Companies by these tags.

Company Name History Information :

Effective DatePrevious Name
LIAONING NOURCHEM PHARMACEUTICAL CHEMICAL CORP. LIMITED05-OCT-2007
EVERBRIGHT PHARMACEUTICAL CORP. LIMITED15-MAR-2010

FAQs:

When was Everbright Pharmaceutical Corp. Limited incorporated?

Everbright Pharmaceutical Corp. Limited was incorporated on 05-OCT-2007 in Hongkong.

What is the type of Everbright Pharmaceutical Corp. Limited?

Everbright Pharmaceutical Corp. Limited is classified as Private company limited by shares.

What is the current status of Everbright Pharmaceutical Corp. Limited Company?

The status of Everbright Pharmaceutical Corp. Limited is Live.

What is the CR Number of Everbright Pharmaceutical Corp. Limited?

The CR Number of Everbright Pharmaceutical Corp. Limited is 1173046.

* We are trying our best to keep all the data correct and up-to-date. It should be noted that it is not the primary source of the information on the company Everbright Pharmaceutical Corp. Limited. The official registry should always be referred for latest information.

Last Updated on 14-09-2016.

Check other companies added on 14-09-2016

Check out Companies Incorporated on 05-OCT-2007: